p53 aggregation promotes transformation from non-malignant lesions to high-grade serous ovarian carcinomas

被引:0
作者
Sartini, Sara
Omholt, Lexi
Moatamed, Neda A.
Soragni, Alice
机构
关键词
D O I
10.1158/1538-7445.AM2024-3027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3027
引用
收藏
页数:2
相关论文
共 50 条
[41]   Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing [J].
Alexander J. Cole ;
Trisha Dwight ;
Anthony J. Gill ;
Kristie-Ann Dickson ;
Ying Zhu ;
Adele Clarkson ;
Gregory B. Gard ;
Jayne Maidens ;
Susan Valmadre ;
Roderick Clifton-Bligh ;
Deborah J. Marsh .
Scientific Reports, 6
[42]   Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer [J].
Raab, Monika ;
Kostova, Izabela ;
Pena-Llopis, Samuel ;
Fietz, Daniela ;
Kressin, Monika ;
Aberoumandi, Seyed Mohsen ;
Ullrich, Evelyn ;
Becker, Sven ;
Sanhaji, Mourad ;
Strebhardt, Klaus .
CANCER COMMUNICATIONS, 2024, 44 (01) :101-126
[43]   SHH and IHH Protein Expression in High-Grade Serous Ovarian Carcinomas [J].
Karin-Kujundzic, Valentina ;
Skrtic, Anita ;
Vranic, Semir ;
Serman, Ljiljana .
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) :772-772
[44]   Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas [J].
He, Qi-zhi ;
Luo, Xue-zhen ;
Wang, Kai ;
Zhou, Qian ;
Ao, Hong ;
Yang, Yan ;
Li, Shu-xia ;
Li, Ying ;
Zhu, Hui-ting ;
Duan, Tony .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 33 (01) :173-184
[45]   A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas [J].
Soragni, Alice ;
Janzen, Deanna M. ;
Johnson, Lisa M. ;
Lindgren, Anne G. ;
Anh Thai-Quynh Nguyen ;
Tiourin, Ekaterina ;
Soriaga, Angela B. ;
Lu, Jing ;
Jiang, Lin ;
Faull, Kym F. ;
Pellegrini, Matteo ;
Memarzadeh, Sanaz ;
Eisenberg, David S. .
CANCER CELL, 2016, 29 (01) :90-103
[46]   THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRECANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA [J].
Greening, Kendall ;
Karnezis, Anthony ;
Cochrane, Dawn ;
Hanley, Gillian ;
Huntsman, David .
CLINICAL CANCER RESEARCH, 2019, 25 (22) :44-44
[47]   The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome [J].
Wojnarowicz, Paulina M. ;
Oros, Kathleen Klein ;
Quinn, Michael C. J. ;
Arcand, Suzanna L. ;
Gambaro, Karen ;
Madore, Jason ;
Birch, Ashley H. ;
de Ladurantaye, Manon ;
Rahimi, Kurosh ;
Provencher, Diane M. ;
Mes-Masson, Anne-Marie ;
Greenwood, Celia M. T. ;
Tonin, Patricia N. .
PLOS ONE, 2012, 7 (09)
[48]   Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer [J].
Qu, Hui ;
Xia, Yu ;
Li, Xiuqin .
CURRENT GENE THERAPY, 2020, 20 (04) :313-320
[49]   SCOUTS, P53 SIGNATURES AND STIC: INSIGHT INTO DEVELOPMENT OF HIGH GRADE PELVIC SEROUS CARCINOMAS [J].
Aggarwal, I. M. ;
Lim, Y. H. ;
Lim, Y. K. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) :372-373
[50]   Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin [J].
Shponka, I. S. ;
Poslavska, O., V ;
Savchenko, O. A. .
MEDICNI PERSPEKTIVI, 2020, 25 (01) :79-87